Shopping Cart
- Remove All
- Your shopping cart is currently empty
Banoxantrone (AQ4N), a hypoxia-selective cytotoxin prototype, undergoes reduction to AQ4, effectively inhibiting topoisomerase II. It selectively targets and eradicates hypoxic cells through an iNOS-dependent mechanism. This compound demonstrates significant cytotoxicity with its hypoxia-selective action being augmented by radiation.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | Inquiry | 1-2 weeks | |
50 mg | Inquiry | 1-2 weeks | |
100 mg | Inquiry | 1-2 weeks |
Description | Banoxantrone (AQ4N), a hypoxia-selective cytotoxin prototype, undergoes reduction to AQ4, effectively inhibiting topoisomerase II. It selectively targets and eradicates hypoxic cells through an iNOS-dependent mechanism. This compound demonstrates significant cytotoxicity with its hypoxia-selective action being augmented by radiation. |
Alias | AQ4N |
Molecular Weight | 444.48 |
Formula | C22H28N4O6 |
Cas No. | 136470-65-0 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.